HR Execs on the Move

Rutland Regional Medical Center

www.rrmccareers.org

 
To be the Best Community Healthcare System in New England. About Rutland Regional Medical Center The biggest community hospital in Vermont and the second largest hospital in the state, Rutland Regional Medical Center has been providing high quality healthcare to the Rutland Region for more than 100 years. As the needs of our community have grown and changed, so has Rutland Regional, adding services, staff and facilities. Today, Rutland Regional Medical Center is a 144 bed hospital, employing over 1,600 professional and support staff including 227 providers trained in 36 specialty areas. Providing preventive, diagnostic, acute and rehabilitative services, Rutland ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Hialeah Hospital

Hialeah Hospital is a 378-bed acute care facility with an experienced medical staff of more than 900 employees. Since we first opened our doors in 1951, we have provided compassionate care to our neighbors and their friends and families. Because we know hospital trips are especially challenging for our elderly neighbors, we provide specially designed senior services including a Senior ER and an Acute Care for the Elderly (ACE) Unit.

Mediflex Surgical Products

Mediflex Surgical Products is a Pittsboro, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Body Zone

Body Zone is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sigvaris Inc

Sigvaris Inc is a Peachtree City, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.